SBI Life Insurance Company
SBI Life Insurance is India's largest private-sector life insurer, selling savings, protection and pension policies mainly through State Bank of India's branch network.
- P/E ~64x
- At 52-wk low
- VNB margin ~29%
- GST hit to Q2 PAT
- No pledge, 55% promoter
Updated on 30 Oct 2026 · Data as of 29 Oct 2026
Get this report as a PDF free, straight to your inbox.
Snapshot
- Share price
- ₹1,652.00
- 29 Oct 2026
- 52-week range
- ₹1,633.00 – ₹2,106.67
- All-time peak
- ₹2,106.67
- 23 Feb 2026 · −21.6% from peak
- Dividend yield
- 0.16%
- Price history since
- 2017
- About 9 years of prices
What's happening
Q2 FY27 results (quarter to Sept 30, 2026) were released on Oct 27, 2026: reported profit of Rs 549 crore, up 11% YoY but below the roughly Rs 610 crore analysts expected. Management said the miss was mostly an accounting effect of the GST exemption on individual life/health premiums (effective Sept 2026), which cost the company lost input tax credit; excluding that, H1 FY27 PAT would have grown 39% instead of the reported 17%. The stock touched a fresh 52-week low (around Rs 1,617-1,634) in the days around the results.
In plain terms
SBI Life collects premiums today and promises payouts later, so the real profit signal for an insurer isn't quarterly PAT alone but how profitable each new policy is (VNB margin, near 29% this quarter) and how much its pool of future obligations is worth (Embedded Value, up 15% to Rs 80,790 crore). This quarter's 11% reported profit growth looks weak, but that's largely a one-off GST accounting change — strip it out and underlying profit grew much faster. The tension: the insurance-specific numbers look healthy, yet the stock has fallen over 20% from its February 2026 high and sits at a 52-week low, so the market is pricing in either slower growth ahead or simply unwinding a rich valuation.
Quarters
Q2 FY27: net profit Rs 549 crore vs Rs 494.6 crore a year ago (+11.1%) — but management flagged this as not comparable like-for-like: the GST exemption on individual life/health premiums cost the company an estimated Rs 530 crore of lost input tax credit in H1 FY27. Excluding that one-off, H1 PAT would have grown 39% (to Rs 1,690 crore) rather than the reported 17% (to Rs 1,274 crore). APE for the quarter was Rs 6,370 crore and VNB margin rose to roughly 29% (29.2-29.3% depending on source) from 27.9% a year ago, above the company's own guided 26-28% band; management attributed about 70bps of the H1 margin gain to yield-curve movement rather than a structural shift, and kept full-year guidance unchanged (26-28% margin, 14-15% premium growth). FY26 (year to March 2026) full-year PAT was Rs 2,470 crore and VNB margin was 27.5%.
Performance
Share price
−16.0% over 1 year
Returns by period
| Period | SBI Life Insurance Company | Nifty 50 | HDFC Life Insurance Company |
|---|---|---|---|
| 3 months | −12.0% | −5.7% | −5.2% |
| 1 year | −16.0% | −12.0% | −31.9% |
| 3 years | +25.2% | +19.8% | −14.1% |
| 5 years | +45.6% | +29.8% | −22.8% |
₹100 invested on 29 Oct 2021 became…
- SBI Life Insurance Company₹146
- Nifty 50₹130
- HDFC Life Insurance Company₹77
The stock closed at Rs 1,652 on Oct 29, 2026, down 21.6% from its Feb 2026 peak of Rs 2,106.67, and sits at its 52-week low (Rs 1,633). There is no split, bonus or demerger on record, so this is a genuine price decline, not a return understated by a corporate action. Over 3 months the stock is down 12%, worse than the Nifty's -5.7% and peer HDFC Life's -5.2% — recent momentum is clearly negative. Zoom out and the picture flips: over 3 years SBI Life is up 25.2% versus Nifty's 19.8% and HDFC Life's -14.1%, and over 5 years it is up 45.6% versus Nifty's 29.8% and HDFC Life's -22.8%. The long-term holder has beaten both the index and its direct peer; it is specifically the last year that has been weak.
Dividend
Paid in the last 12 months
₹2.70 per share
Dividend yield
0.16%
Dividend yield is the last 12 months of dividends divided by today's share price. A 0.2% yield means every ₹100 of SBI Life Insurance Company shares paid about ₹0.2 in dividends over the past year. Past payouts can change.
Recent dividends
| Date | Per share |
|---|---|
| 6 Mar 2026 | ₹2.70 |
| 7 Mar 2025 | ₹2.70 |
| 15 Mar 2024 | ₹2.70 |
| 16 Mar 2023 | ₹2.50 |
| 29 Mar 2022 | ₹2.00 |
| 5 Apr 2021 | ₹2.50 |
| 3 Apr 2019 | ₹2.00 |
| 3 Apr 2018 | ₹2.00 |
Valuation
On conventional equity multiples SBI Life looks expensive — trailing P/E is reported around 63.9x by some sources and near 66x by others (one source's 78-79x figure looks like an outlier against this cluster and is set aside), with P/B around 8.5x. These aren't the natural lens for a life insurer though: insurers are more usefully priced against Embedded Value, where the stock trades at roughly 2x its March 2026 EV per share of Rs 805.4. Why it looks 'expensive' on P/E: insurance accounting defers much of a policy's economic profit into future years, so current PAT understates value creation, and the market is paying for EV growth (RoEV 19.7% in FY26) rather than this year's earnings. Whether that premium is justified is separate — at ~2x EV it is priced for continued double-digit EV growth and stable margins, and any slippage would compress the multiple, which is arguably part of why the stock has de-rated since February 2026.
Growth
Growth here is both margin-led and volume-led, not one or the other. New business volumes (APE) are growing (~14-15% annual premium growth guided for FY27), while VNB margin has also expanded (27.9% to ~29% YoY in Q2) — a healthier combination than margin expansion alone, since volume reflects genuine distribution reach through SBI's bank branches rather than pricing games.
Health
This is an insurer, so 'cash conversion' isn't the usual manufacturing-style check — profits sit mostly in actuarial reserves plus a shareholders' surplus. The relevant checks are solvency and persistency: solvency ratio was 1.90x at FY26-end, comfortably above the regulatory minimum, and persistency has been improving (13th-month 87.9%, +53bps YoY; 49th-month 69.1%, +107bps YoY). There is no balance-sheet distress evident; the real risk to watch is business risk — dependence on SBI's bancassurance channel, product mix shifts, and the GST-related cost headwind — rather than financial risk.
Ownership
Promoters (State Bank of India together with BNP Paribas Cardif) hold 55.3%, stable over the last four quarters with no pledging reported. FIIs have trimmed their stake from 21.9% a year ago to 20.7% now, while domestic institutions (including mutual funds, holding close to 16%) have added, from 18.7% to 20.1%. There is no well-known individual or marquee investor on the register driving the narrative here — ownership is dominated by the SBI promoter group and broad institutional holders.
The View
The one thing to watch
Whether VNB margin holds within the company's own 26-28% guided band through H2 FY27 once the GST input-tax-credit drag fully works through the numbers - that will show whether Q2's ~29% margin and the 39% ex-GST profit growth were a durable run-rate or a one-quarter high.
Strengths
- +VNB margin of ~29% in Q2 FY27, above the company's own guided 26-28% range and up from 27.9% a year ago
- +Embedded Value up 15% YoY to Rs 80,790 crore with RoEV of 19.7% (FY26)
- +Persistency improving across durations (13th month 87.9%, +53bps YoY; 49th month 69.1%, +107bps YoY)
- +Solvency ratio of 1.90x, comfortably above the regulatory minimum, with no promoter pledging
Watchpoints
- !GST-related loss of input tax credit depressed reported H1 FY27 PAT growth to 17% versus an underlying ~39% - the size of this drag going forward is uncertain
- !Stock is at a 52-week low, down 21.6% from its Feb 2026 peak, and has underperformed the Nifty over 3 months (-12% vs -5.7%) and 1 year (-16% vs -12%)
- !Conventional valuation multiples are rich (P/E ~64x, P/B ~8.5x; ~2x Embedded Value), leaving little room for a slip in margin or growth
- !FII holding has declined from 21.9% to 20.7% YoY even as execution needs to stay on track against the company's own 26-28% margin / 14-15% growth guidance
How sure are we about the data? · Moderate
Cross-checked PAT, VNB margin, Embedded Value and premium growth across multiple sources (ICICI Direct, Zeebiz, Business Standard, earnings-call commentary) which were broadly consistent. P/E estimates varied (63.9x, 66x, and one 78-79x outlier set aside as inconsistent with the cluster); P/B (~8.5x) and P/EV (~2x, using FY26-end EV/share) could not be independently verified against a primary filing - check on Screener. Exact Q3 FY27 results date and next dividend record date were not found - Not verified, check BSE/NSE announcements.
Keep it for later
Get the SBI Life Insurance Company report as a PDF
The full report, neatly laid out with charts and tables, sent to your inbox. Handy to read offline or share.
Reports are refreshed every quarter, about three days after each company announces its results.
Ticker Tales is not a SEBI-registered investment adviser or research analyst. This report is for learning only and is not investment advice. Data as of 29 Oct 2026.